Application of TMEM100 in regulating and controlling 5-fluorouracil drug resistance of lung cancer
The invention relates to the technical field of medicine, in particular to application of TMEM100 in regulation and control of lung cancer 5-fluorouracil drug resistance. Experiments prove that expression of TMEM100 in lung cancer drug-resistant cell strains is reduced; tMEM100 overexpression inhibi...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YE ZAITING YIN ZHANGYONG CAO ZHUO CAI XIAOPING PAN JIONGWEI XU CUNLAI |
| description | The invention relates to the technical field of medicine, in particular to application of TMEM100 in regulation and control of lung cancer 5-fluorouracil drug resistance. Experiments prove that expression of TMEM100 in lung cancer drug-resistant cell strains is reduced; tMEM100 overexpression inhibits the activity of lung cancer drug-resistant cell strains and enhances the sensitivity of cells to 5-FU; the TMEM100 overexpression reduces the proliferation of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU; the overexpression of TMEM100 promotes the apoptosis of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU.
本发明涉及医药技术领域，尤其涉及TMEM100在调控肺癌5-氟尿嘧啶耐药的应用，本发明通过实验证明，TMEM100在肺癌耐药细胞株中表达降低；TMEM100过表达抑制肺癌耐药细胞株的活力，增强细胞对5-FU的敏感性；TMEM100过表达降低了肺癌耐药细胞株的增殖，增强了细胞对5-FU的敏感性；TMEM100过表达促进了肺癌耐药细胞株的凋亡，增强了细胞对5-FU的敏感性。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN114870017A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN114870017A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN114870017A3</originalsourceid><addsrcrecordid>eNqNjE0KwjAQRrtxIeodxgMUElTabSkVN3XVfYnpNASGmZCf-9uCB3D18fge71h9uhDIW5O9MMgK0ziMWinwDBFdoe1gB4YXsMI5CtHOj3qlIlFKNNYTLLG4TU8-ZcMW9w6VTbM7xXN1WA0lvPz2VF2fw9S_agwyYwrGImOe-7fW97ZRSjfd7R_nC6jbPQo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of TMEM100 in regulating and controlling 5-fluorouracil drug resistance of lung cancer</title><source>esp@cenet</source><creator>YE ZAITING ; YIN ZHANGYONG ; CAO ZHUO ; CAI XIAOPING ; PAN JIONGWEI ; XU CUNLAI</creator><creatorcontrib>YE ZAITING ; YIN ZHANGYONG ; CAO ZHUO ; CAI XIAOPING ; PAN JIONGWEI ; XU CUNLAI</creatorcontrib><description>The invention relates to the technical field of medicine, in particular to application of TMEM100 in regulation and control of lung cancer 5-fluorouracil drug resistance. Experiments prove that expression of TMEM100 in lung cancer drug-resistant cell strains is reduced; tMEM100 overexpression inhibits the activity of lung cancer drug-resistant cell strains and enhances the sensitivity of cells to 5-FU; the TMEM100 overexpression reduces the proliferation of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU; the overexpression of TMEM100 promotes the apoptosis of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU.
本发明涉及医药技术领域，尤其涉及TMEM100在调控肺癌5-氟尿嘧啶耐药的应用，本发明通过实验证明，TMEM100在肺癌耐药细胞株中表达降低；TMEM100过表达抑制肺癌耐药细胞株的活力，增强细胞对5-FU的敏感性；TMEM100过表达降低了肺癌耐药细胞株的增殖，增强了细胞对5-FU的敏感性；TMEM100过表达促进了肺癌耐药细胞株的凋亡，增强了细胞对5-FU的敏感性。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220809&DB=EPODOC&CC=CN&NR=114870017A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220809&DB=EPODOC&CC=CN&NR=114870017A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YE ZAITING</creatorcontrib><creatorcontrib>YIN ZHANGYONG</creatorcontrib><creatorcontrib>CAO ZHUO</creatorcontrib><creatorcontrib>CAI XIAOPING</creatorcontrib><creatorcontrib>PAN JIONGWEI</creatorcontrib><creatorcontrib>XU CUNLAI</creatorcontrib><title>Application of TMEM100 in regulating and controlling 5-fluorouracil drug resistance of lung cancer</title><description>The invention relates to the technical field of medicine, in particular to application of TMEM100 in regulation and control of lung cancer 5-fluorouracil drug resistance. Experiments prove that expression of TMEM100 in lung cancer drug-resistant cell strains is reduced; tMEM100 overexpression inhibits the activity of lung cancer drug-resistant cell strains and enhances the sensitivity of cells to 5-FU; the TMEM100 overexpression reduces the proliferation of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU; the overexpression of TMEM100 promotes the apoptosis of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU.
本发明涉及医药技术领域，尤其涉及TMEM100在调控肺癌5-氟尿嘧啶耐药的应用，本发明通过实验证明，TMEM100在肺癌耐药细胞株中表达降低；TMEM100过表达抑制肺癌耐药细胞株的活力，增强细胞对5-FU的敏感性；TMEM100过表达降低了肺癌耐药细胞株的增殖，增强了细胞对5-FU的敏感性；TMEM100过表达促进了肺癌耐药细胞株的凋亡，增强了细胞对5-FU的敏感性。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE0KwjAQRrtxIeodxgMUElTabSkVN3XVfYnpNASGmZCf-9uCB3D18fge71h9uhDIW5O9MMgK0ziMWinwDBFdoe1gB4YXsMI5CtHOj3qlIlFKNNYTLLG4TU8-ZcMW9w6VTbM7xXN1WA0lvPz2VF2fw9S_agwyYwrGImOe-7fW97ZRSjfd7R_nC6jbPQo</recordid><startdate>20220809</startdate><enddate>20220809</enddate><creator>YE ZAITING</creator><creator>YIN ZHANGYONG</creator><creator>CAO ZHUO</creator><creator>CAI XIAOPING</creator><creator>PAN JIONGWEI</creator><creator>XU CUNLAI</creator><scope>EVB</scope></search><sort><creationdate>20220809</creationdate><title>Application of TMEM100 in regulating and controlling 5-fluorouracil drug resistance of lung cancer</title><author>YE ZAITING ; YIN ZHANGYONG ; CAO ZHUO ; CAI XIAOPING ; PAN JIONGWEI ; XU CUNLAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN114870017A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YE ZAITING</creatorcontrib><creatorcontrib>YIN ZHANGYONG</creatorcontrib><creatorcontrib>CAO ZHUO</creatorcontrib><creatorcontrib>CAI XIAOPING</creatorcontrib><creatorcontrib>PAN JIONGWEI</creatorcontrib><creatorcontrib>XU CUNLAI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YE ZAITING</au><au>YIN ZHANGYONG</au><au>CAO ZHUO</au><au>CAI XIAOPING</au><au>PAN JIONGWEI</au><au>XU CUNLAI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of TMEM100 in regulating and controlling 5-fluorouracil drug resistance of lung cancer</title><date>2022-08-09</date><risdate>2022</risdate><abstract>The invention relates to the technical field of medicine, in particular to application of TMEM100 in regulation and control of lung cancer 5-fluorouracil drug resistance. Experiments prove that expression of TMEM100 in lung cancer drug-resistant cell strains is reduced; tMEM100 overexpression inhibits the activity of lung cancer drug-resistant cell strains and enhances the sensitivity of cells to 5-FU; the TMEM100 overexpression reduces the proliferation of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU; the overexpression of TMEM100 promotes the apoptosis of lung cancer drug-resistant cell strains, and enhances the sensitivity of cells to 5-FU.
本发明涉及医药技术领域，尤其涉及TMEM100在调控肺癌5-氟尿嘧啶耐药的应用，本发明通过实验证明，TMEM100在肺癌耐药细胞株中表达降低；TMEM100过表达抑制肺癌耐药细胞株的活力，增强细胞对5-FU的敏感性；TMEM100过表达降低了肺癌耐药细胞株的增殖，增强了细胞对5-FU的敏感性；TMEM100过表达促进了肺癌耐药细胞株的凋亡，增强了细胞对5-FU的敏感性。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN114870017A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Application of TMEM100 in regulating and controlling 5-fluorouracil drug resistance of lung cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A44%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YE%20ZAITING&rft.date=2022-08-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN114870017A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |